Government ❯U.S. Government

Health Policies

Vaccine Technology Vaccines Health Policies Vaccine Research Human Health Vaccine Technology Clinical Trials Public Health Response Moderna Infectious Diseases

HHS Ends $600 Million Moderna Deal for H5N1 Vaccine Development

Health Secretary Robert F. Kennedy Jr.’s mistrust of mRNA platforms prompted the decision despite promising Phase 1/2 data for the H5N1 project.

Moderna Secures $590M U.S. Grant to Advance Bird Flu Vaccine Development